De Burlo Group Inc Abiomed Inc Transaction History

De Burlo Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 07, 2019	SELL	$175.89 - $279.23 $589,231 - $935,420	-3,350 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$250.96 - $284.94 $1.03 Million - $1.17 Million	-4,100 Reduced 55.03%	3,350 $873,000
Q1 2019 May 09, 2019	SELL	$276.39 - $362.25 $483,682 - $633,937	-1,750 Reduced 19.02%	7,450 $2.13 Million
Q4 2018 Feb 07, 2019	SELL	$281.08 - $444.25 $28,108 - $44,425	-100 Reduced 1.08%	9,200 $2.99 Million
Q3 2018 Nov 08, 2018	SELL	$354.53 - $449.75 $11.9 Million - $15.1 Million	-33,600 Reduced 78.32%	9,300 $4.18 Million
Q2 2018 Aug 10, 2018	SELL	$278.07 - $446.21 $3.35 Million - $5.38 Million	-12,050 Reduced 21.93%	42,900 $17.5 Million
Q1 2018 May 03, 2018	BUY	$192.49 - $295.85 $1.06 Million - $1.63 Million	5,500 Added 11.12%	54,950 $16 Million
Q4 2017 Feb 08, 2018	BUY	$168.78 - $199.74 $5.49 Million - $6.5 Million	32,550 Added 192.6%	49,450 $9.27 Million
Q3 2017 Nov 02, 2017	BUY	$145.39 - $168.6 $2.46 Million - $2.85 Million	16,900	16,900 $2.85 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

Stay updated on De Burlo Group Inc with notifications on news.